Amgen (AMGN) FCF Margin (2009 - 2026)
Amgen (AMGN) posted quarterly FCF Margin of 17.14% for Q1 2026, up 511.0% year-over-year from 2.8% in Q1 2025, and up 75.95% quarter-over-quarter from 9.74% in Q4 2025.
Amgen (AMGN) FCF Margin (2009 - 2026) Analysis & Trends
Amgen's FCF Margin history runs 18 years deep, the most recent figure standing at 17.14% for Q1 2026.
- In Q1 2026, FCF Margin rose 511.0% year-over-year to 17.14%; the TTM figure through Mar 2026 stood at 23.1% (down 889.0% YoY), while the FY2025 annual figure was 22.04%, down 906.0% from the prior year.
- FCF Margin for Q1 2026 stood at 17.14%, up from 9.74% in the prior quarter.
- The five-year high for FCF Margin was 503.05% in Q4 2022, with the low at 3.53% in Q4 2023.
- The 5-year median for FCF Margin is 26.48% (2024), against an average of 54.91%.
- The sharpest annual moves came in 2022 and 2023: FCF Margin soared 46623 bps in 2022, then tumbled 49952 bps in 2023.
- Amgen's FCF Margin stood at 503.05% in 2022, then plunged by 99 bps to 3.53% in 2023, then surged by 1273 bps to 48.43% in 2024, then tumbled by 80 bps to 9.74% in 2025, then surged by 76 bps to 17.14% in 2026.
- Business Quant data shows AMGN's FCF Margin at 17.14% in Q1 2026, 9.74% in Q4 2025, and 44.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 38.60% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | -12.07% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 2.01% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 3.90% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.70% |
| Mar 31, 2026 | 17.14% |
| Dec 31, 2025 | 9.74% |
| Sep 30, 2025 | 44.45% |
| Jun 30, 2025 | 20.82% |
| Mar 31, 2025 | 12.03% |
| Dec 31, 2024 | 48.43% |
| Sep 30, 2024 | 38.97% |
| Jun 30, 2024 | 26.48% |
| Mar 31, 2024 | 6.16% |
| Dec 31, 2023 | 3.53% |
| Sep 30, 2023 | 36.39% |
| Jun 30, 2023 | 54.94% |
| Mar 31, 2023 | 11.79% |
| Dec 31, 2022 | 503.05% |
| Sep 30, 2022 | 42.36% |
| Jun 30, 2022 | 25.54% |
| Mar 31, 2022 | 31.64% |
| Dec 31, 2021 | 36.82% |
| Sep 30, 2021 | 32.45% |